From Isolates to Microbiomes: Utilization and Expansion of Metaproteomics to Understand Microbial Systems for Biotechnology and Human Health Applications
Date Issued
August 2026
Author(s)
Davin, Megan
The University of Tennessee
Advisor(s)
Robert L Hettich
Additional Advisor(s)
Gladys Alexandre
Timothy J Tschaplinski
Jennifer L Morrell-Falvey
Heidi Goodrich-Blair
Abstract
Microorganisms drive essential processes in both engineered and natural environments. Their diverse metabolic activities allow for unique applications such as biofuel production, and in host-associated microbiomes, they are closely tied to human health. Linking microbial activity to downstream effects remains a central challenge. Proteomics, via high-throughput mass spectrometry, provides a powerful way to directly measure the active molecular machinery of cells and communities, offering insight into metabolic states, interspecies interactions, and host–microbe relationships. My dissertation applies liquid chromatography tandem mass spectrometry (LC-MS/MS)-based proteomics to microbial systems spanning engineered biofuel-producing strains, synthetic microbial cultures, and the human gut microbiome. Across these contexts, I use proteomic analysis to reveal organism adaptation, cooperation, and competition. First, I utilize proteomics to reveal pathway-level fluxes in engineered isolates relevant to biofuel production, identifying stress responses and metabolic bottlenecks. Second, I apply proteomics to synthetic and natural microbial consortia, showing how division of labor and metabolic handoffs enable degradation of complex substrates. Third, I extend these approaches to the human gut microbiome, where metaproteomic measurements link microbial activities to host physiology. I expand the metaproteomic search space with the detection of small proteins within the gut microbiome, expanding resolution of microbial functions often missed in standard analyses and offering a more complete picture of the gut microbiomes behavior in patients with Parkinson's disease and Rheumatoid Arthritis. Together, these studies use proteomics to advance metabolic engineering for sustainable bioenergy and deepen understanding of microbiome function in health and disease.
Degree
Doctor of Philosophy
Major
Life Sciences
Embargo Date
August 1, 2027